Close
Close

Pfizer - Pulmonary Arterial Hypertension

Partner

Not provided

Rare Disease

Pulmonary Arterial Hypertension

Sponsor

Pfizer

Access Program Information

The purpose of this study is to provide Sildenafil therapy for subjects who completed A1481156 study and are judged by the investigator to derive clinical benefit from continued treatment with Sildenafil, prior to reimbursement and availability for subjects in the Russian Federation.

Contact

Contact: Pfizer CT.gov Call Center (1-800-718-1021)

Locations
  • Russian Federation

Free Newsletter